DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 121.18 billion Korean Won [US$102.39 million]
of which 42%
was Pharmaceutical Business),
Ctc Bio, Incorporation.
(118.99 billion Korean Won [US$100.55 million]
CKD Bio Corp
(106.69 billion Korean Won [US$90.15 million]
of which 100%
was Pharmaceutical Manufacturing).
DaehanPharmaceutical reported sales of 124.28 billion Korean Won (US$105.01 million)
December of 2015.
increase of 11.2%
versus 2014, when the company's sales were 111.71 billion Korean Won.
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2010, sales have increased a total of 71%).